Literature DB >> 4913945

Microangiopathic hemolytic anemia.

M C Brain.   

Abstract

Entities:  

Mesh:

Year:  1970        PMID: 4913945     DOI: 10.1146/annurev.me.21.020170.001025

Source DB:  PubMed          Journal:  Annu Rev Med        ISSN: 0066-4219            Impact factor:   13.739


× No keyword cloud information.
  7 in total

1.  [On primary and secondary malignant nephrosclerosis (author's transl)].

Authors:  A Bohle; U Helmchen; D Meyer; K D Bock; L Brüning; H H Edel; V Heimsoth; F Scheler
Journal:  Klin Wochenschr       Date:  1973-09-01

2.  Cerebral microangiopathy in stroke-prone spontaneously hypertensive rats. An immunohistochemical and ultrastructural study.

Authors:  K Fredriksson; C Nordborg; H Kalimo; Y Olsson; B B Johansson
Journal:  Acta Neuropathol       Date:  1988       Impact factor: 17.088

3.  Endotheliotropic (hemolytic) nephroangiopathy and its various manifestation forms (thrombotic microangiopathy, primary malignant nephrosclerosis, hemolytic-uremic syndrome).

Authors:  W Thoenes; H D John
Journal:  Klin Wochenschr       Date:  1980-02-15

Review 4.  Postoperative severe microangiopathic hemolytic anemia associated with a giant hepatic cavernous hemangioma.

Authors:  Kaysie L Banton; Jonathan D'Cunha; Noel Laudi; Catherine Flynn; Dale Hammerschmidt; Abhinav Humar; Timothy Sielaff
Journal:  J Gastrointest Surg       Date:  2005 May-Jun       Impact factor: 3.452

5.  Increased sodium appetite and polydipsia induced by partial aortic occlusion in the rat.

Authors:  M Costales; J T Fitzsimons; M Vijande
Journal:  J Physiol       Date:  1984-07       Impact factor: 5.182

6.  The effects of heparin treatment on hypertension and vascular lesions in stroke-prone spontaneously hypertensive rats.

Authors:  S K Wilson; K Solez; J K Boitnott; R H Heptinstall
Journal:  Am J Pathol       Date:  1981-01       Impact factor: 4.307

7.  Development of an experimental hemolytic uremic syndrome in rats.

Authors:  Elsa Zotta; Nestor Lago; Federico Ochoa; Horacio A Repetto; Cristina Ibarra
Journal:  Pediatr Nephrol       Date:  2008-02-06       Impact factor: 3.714

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.